PCSK9 and familial hyperaldosteronism: In this study, we aim to evaluate the effect of PCSK9-i on sexual function evaluated by the Male Sexual Health Questionnaire (MSHQ) and the International Index of Erectile Function (IIEF-5) questionnaire and on early atherosclerosis injury evaluated by pulse wave velocity (PWV) in a cohort of FH male subjects.